What is Central Diabetes Insipidus in Holoprosencephaly?
At a Glance
Central diabetes insipidus in holoprosencephaly is a critical water and salt balance disorder, not a blood sugar issue. It occurs when brain malformations prevent the production of antidiuretic hormone, requiring strict fluid management and desmopressin (DDAVP) medication.
In this answer
4 sections
When you hear the word “diabetes,” it is natural to immediately think of blood sugar, insulin, and diet. However, if your baby with holoprosencephaly (HPE) has been diagnosed with central diabetes insipidus (CDI), it has absolutely nothing to do with blood sugar [1].
Central diabetes insipidus (increasingly referred to by doctors as arginine vasopressin deficiency or AVP-D) is a completely different condition. It is a critical issue of water and salt balance caused by the brain’s inability to produce a specific hormone that controls how the kidneys handle water [1][2]. Because HPE involves malformations of the midline of the brain, the hypothalamus and pituitary gland—the structures responsible for producing and releasing this hormone—are often underdeveloped or absent [3][4].
Understanding the stark difference between central diabetes insipidus and “regular” diabetes (diabetes mellitus) is essential for managing your child’s care and keeping them safe.
The Difference Between the “Two” Diabetes
- Diabetes Mellitus (“Regular” Diabetes): The pancreas does not make enough insulin, leading to high blood sugar levels.
- Central Diabetes Insipidus (CDI): The pituitary gland does not make enough antidiuretic hormone (ADH, also called vasopressin) [1]. This hormone acts as a signal telling the kidneys to hold onto water and concentrate the urine [5]. Without ADH, the kidneys constantly dump water out of the body as clear, dilute urine, leading to rapid, life-threatening dehydration and dangerously high sodium levels in the blood (hypernatremia) [6][2].
Recognizing the Signs in an HPE Infant
Because a baby cannot tell you they are thirsty, recognizing the signs of CDI is crucial. Symptoms in an infant with HPE include:
- Excessive, constant urination (polyuria): You may notice rapidly soaking-wet, heavy diapers that need changing far more frequently than normal, sometimes completely soaking through clothes within an hour [1][7].
- Severe dehydration: Physical signs include a sunken soft spot (fontanelle) on the head, dry mouth, and no tears when crying.
- Hypernatremia (high sodium levels): As water leaves the body, the salt (sodium) left behind becomes highly concentrated in the blood [6][7]. This can cause inconsolable irritability, muscle twitches, and in severe cases, seizures.
When to Seek Emergency Care: If your baby becomes severely lethargic, unresponsive, or is having a seizure, this is a medical emergency. Go to the nearest Emergency Room immediately.
A Unique Danger in HPE: Adipsic Diabetes Insipidus
Normally, a person with diabetes insipidus experiences extreme thirst to replace the lost fluids. However, because of the brain malformations in HPE, some babies lack a normal thirst drive (called adipsic diabetes insipidus) [8]. They may not cry for a bottle even when they are dangerously dehydrated [9][10]. This makes a strict, physician-guided scheduled fluid management plan completely essential [10].
Standard Treatment: Desmopressin (DDAVP)
While CDI is a very serious condition, it is highly treatable. The standard treatment is a medication called desmopressin (DDAVP), which is a synthetic version of the missing antidiuretic hormone [11][1]. Desmopressin works rapidly to slow down urine production and keep water in the body [11][12].
Because many babies with HPE have craniofacial anomalies (like a single nostril or a cleft) that make nasal sprays ineffective or impossible, the medication is usually given in other ways. For infants, a rapidly dissolving form of desmopressin (a “melt”) is often placed inside the cheek (buccally) or under the tongue (sublingually) [13]. Many infants with HPE rely on a G-tube (gastrostomy tube) for feeding, which can also be an excellent, precise way to deliver both their scheduled fluids and diluted liquid medications [14]. In emergency hospital settings, continuous intravenous fluids may be used to stabilize sodium levels [15].
Sick Day Management: A Critical Warning
If your baby has a stomach bug and is vomiting or has diarrhea, they can rapidly develop life-threatening sodium imbalances. If they cannot keep their scheduled fluids or their DDAVP dose down, do not wait. Contact your endocrinologist immediately or go directly to the ER. Managing a “sick day” requires close medical guidance, and often IV fluids, to keep your baby safe.
The Crucial Role of the Pediatric Endocrinologist
Managing central diabetes insipidus requires the close supervision of a pediatric endocrinologist. Finding the right balance of medication and fluid intake is an ongoing process.
- Preventing “Water Intoxication”: If a baby is given desmopressin but then takes in too much fluid, the body holds onto excess water. This dilutes the blood sodium too much, causing hyponatremia (low sodium) [16][17]. This is just as dangerous as high sodium and requires absolute vigilance [18].
- Frequent Blood Monitoring: Your child will need frequent laboratory blood draws to monitor their electrolyte levels, especially sodium [17][19]. The endocrinologist will use these lab results to carefully adjust the DDAVP dose and provide you with a strict, scheduled fluid intake plan based on your baby’s weight and needs [10][20].
Safety Tip: Always attach a medical ID tag or card to your baby’s car seat, stroller, and diaper bag that clearly states: “Central Diabetes Insipidus / AVP-D – No Insulin.” This ensures that in an emergency, first responders or unfamiliar caregivers do not mistakenly treat your child for blood sugar issues. With meticulous management and the guidance of an expert care team, the severe risks of CDI can be successfully controlled, ensuring your baby maintains a safe and stable fluid balance [21][11].
Common questions in this guide
What is the difference between central diabetes insipidus and regular diabetes?
What are the signs of central diabetes insipidus in an infant?
Why doesn't my baby act thirsty when they are dehydrated?
How is central diabetes insipidus treated in babies with holoprosencephaly?
What should I do if my baby with CDI gets a stomach bug?
Why does my baby need frequent blood draws for this condition?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What is our specific 'sick day plan' if my baby vomits their scheduled fluids or spits up their DDAVP dose?
- 2.At what point should I call the on-call endocrinologist versus taking my baby straight to the emergency room for suspected dehydration or fluid imbalance?
- 3.Given my baby's facial anatomy and feeding abilities, what is the safest and most reliable way to administer their desmopressin (e.g., buccal melt, oral liquid, or through their G-tube)?
- 4.How often do you need to check my baby's sodium levels, and where is the best place to go to get those labs drawn quickly?
- 5.If my baby seems unusually lethargic or irritable, how can I safely tell if it is due to high sodium (dehydration) or low sodium (water intoxication)?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (21)
- 1
Changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidus.
Arima H, Cheetham T, Christ-Crain M, et al.
Clinical endocrinology 2024; (101(5)):443-445 doi:10.1111/cen.14819.
PMID: 36030512 - 2
Diagnosis and treatment of hypernatremia.
Tomkins M, Mc Donald D, Green D, et al.
Best practice & research. Clinical endocrinology & metabolism 2026; (40(1)):102065 doi:10.1016/j.beem.2025.102065.
PMID: 41203493 - 3
Intravenous formulation of desmopressin delivered via oral and g tube routes for the treatment of central diabetes insipidus: First experience in infants.
Lim WY, Riba-Wolman R
Clinical endocrinology 2020; (92(2)):179-181 doi:10.1111/cen.14125.
PMID: 31715009 - 4
Asymptomatic Hypernatremia in an Infant with Midline Defects.
Geminiganesan S, Ramanan PV, J D, et al.
EJIFCC 2021; (32(4)):467-471.
PMID: 35046765 - 5
Nephrogenic Diabetes Insipidus.
Kavanagh C, Uy NS
Pediatric clinics of North America 2019; (66(1)):227-234 doi:10.1016/j.pcl.2018.09.006.
PMID: 30454745 - 6
Animal models of Central Diabetes Insipidus: Human relevance of acquired beyond hereditary syndromes and the role of oxytocin.
Bernal A, Mahía J, Puerto A
Neuroscience and biobehavioral reviews 2016; (66()):1-14.
PMID: 27118135 - 7
Central Diabetes Insipidus and Brain Herniation Secondary to Cryptococcal Meningitis in a Dog.
Hurst O, Mastrocco A, Prittie J
Clinical case reports 2026; (14(7)):e73095 doi:10.1002/ccr3.73095.
PMID: 42404679 - 8
Adipsic diabetes insipidus.
Kothari V, Cardona Z, Eisenberg Y
Handbook of clinical neurology 2021; (181()):261-273 doi:10.1016/B978-0-12-820683-6.00019-1.
PMID: 34238462 - 9
When Thirst Ceases to Exist: A Case Report and Literature Review of Adipsic Diabetes Insipidus Following Coil Embolization of a Ruptured Anterior Communicating Artery Aneurysm.
Barnett MJ, Patel G, Lekprasert P, et al.
Cureus 2024; (16(7)):e64207 doi:10.7759/cureus.64207.
PMID: 38993626 - 10
Diabetes insipidus.
Levy M, Prentice M, Wass J
BMJ (Clinical research ed.) 2019; (364()):l321 doi:10.1136/bmj.l321.
PMID: 30819684 - 11
Arginine vasopressin deficiency: diagnosis, management and the relevance of oxytocin deficiency.
Atila C, Refardt J, Christ-Crain M
Nature reviews. Endocrinology 2024; (20(8)):487-500 doi:10.1038/s41574-024-00985-x.
PMID: 38693275 - 12
Diabetes Insipidus: A Pragmatic Approach to Management.
Priya G, Kalra S, Dasgupta A, Grewal E
Cureus 2021; (13(1)):e12498 doi:10.7759/cureus.12498.
PMID: 33425560 - 13
[Treatment with sublingual desmopressin in two infants with hydranencephaly and central diabetes insipidus].
Marín GR, Baspineiro B, Vilca I
Archivos argentinos de pediatria 2018; (116(1)):e93-e97 doi:10.5546/aap.2018.e93.
PMID: 29333830 - 14
Oral administration of diluted nasal desmopressin in managing neonatal central diabetes insipidus.
Mavinkurve M, McGrath N, Johnston N, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2017; (30(6)):623-628.
PMID: 28599389 - 15
Challenging case of hypernatraemia in infancy.
Hawton K, Galloway L, Harmer M, et al.
Archives of disease in childhood. Education and practice edition 2025; (110(3)):107-112 doi:10.1136/archdischild-2024-327310.
PMID: 39209372 - 16
A case of cerebral salt wasting syndrome in a patient with central diabetes insipidus and status epilepticus.
Bernardi S, Zorat F, Calabrò V, et al.
Journal of endocrinological investigation 2023; (46(6)):1275-1277 doi:10.1007/s40618-023-02053-z.
PMID: 36932301 - 17
Desmopressin for the prevention of bleeding in percutaneous kidney biopsy: efficacy and hyponatremia.
Lim CC, Siow B, Choo JCJ, et al.
International urology and nephrology 2019; (51(6)):995-1004 doi:10.1007/s11255-019-02155-9.
PMID: 31028561 - 18
Life threatening biphasic adverse reactions to desmopressin: case report and review of the literature.
Wang L, Chen R, Tian F, et al.
International journal of clinical pharmacology and therapeutics 2016; (54(8)):640-4 doi:10.5414/CP202461.
PMID: 27142268 - 19
Case Report-Severe Hyponatremia at Birth in a Premature Infant.
Al-Omari L, Stranberg A, Fuenmayor MF, Jain S
Journal of mother and child 2024; (28(1)):83-86 doi:10.34763/jmotherandchild.20242801.d-24-00006.
PMID: 39442071 - 20
Desmopressin dose requirements in patients with permanent arginine vasopressin deficiency: a tertiary center experience.
Varaldo E, Sibilla M, Prencipe N, et al.
Pituitary 2024; (27(5)):714-722 doi:10.1007/s11102-024-01454-4.
PMID: 39266909 - 21
Diabetes insipidus in infants and children.
Dabrowski E, Kadakia R, Zimmerman D
Best practice & research. Clinical endocrinology & metabolism 2016; (30(2)):317-28.
PMID: 27156767
This page provides educational information about central diabetes insipidus in infants with holoprosencephaly. Always consult your pediatric endocrinologist for specific medical advice, sick day plans, and medication dosages.
Get notified when new evidence is published on Holoprosencephaly.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.